Tenon Medical, Inc. TNON
We take great care to ensure that the data presented and summarized in this overview for Tenon Medical, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in TNON
Top Purchases
Top Sells
About TNON
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.
Insider Transactions at TNON
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Steven M Van Dick Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+33.24%
|
$0
$0.27 P/Share
|
|
May 23
2023
|
Richard Ginn Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
64,990
-43.24%
|
$64,990
$1.26 P/Share
|
|
May 23
2023
|
Steven M Foster CEO and President |
SELL
Open market or private sale
|
Direct |
27,791
-38.34%
|
$27,791
$1.26 P/Share
|
|
May 22
2023
|
Robert K Weigle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,207
+50.0%
|
$6,207
$1.62 P/Share
|
|
May 22
2023
|
Steven M Van Dick Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,433
+37.64%
|
$30,433
$1.62 P/Share
|
|
May 22
2023
|
Frank M Fischer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,207
+50.0%
|
$6,207
$1.62 P/Share
|
|
May 22
2023
|
Richard Ginn Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,308
+50.0%
|
$150,308
$1.62 P/Share
|
|
May 22
2023
|
Ivan Howard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,207
+7.92%
|
$6,207
$1.62 P/Share
|
|
May 22
2023
|
Steven M Foster CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
72,477
+50.0%
|
$72,477
$1.62 P/Share
|
|
May 22
2023
|
Stephen Hochschuler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,207
+19.33%
|
$6,207
$1.62 P/Share
|
|
May 22
2023
|
Richard Ferrari Director |
BUY
Exercise of conversion of derivative security
|
Direct |
91,300
+33.22%
|
$91,300
$1.62 P/Share
|